Human papillomavirus vaccine

Some issues around consent remain unresolved

BMJ 2008; 336 doi: 10.1136/bmj.39583.741921.3A (Published 22 May 2008)
Cite this as: BMJ 2008;336:1146.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Elizabeth C F Brown, academic F2 doctor
  1. 1Southampton University Hospital Trust, Southampton SO16 6YD
  1. elizabeth.brown5{at}nhs.net

    Brabin et al’s success in achieving an uptake of 70% of two doses of human papillomavirus vaccine among adolescent schoolgirls is extremely encouraging.1 However, this pilot study has raised important …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL